Fingerprint
Dive into the research topics of 'Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer
Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina Piha-Paul, Julia Ann Moore, Bulent Yilmaz, Deby Ogbonna, Daniel D. Karp, Ecaterina Ileana Dumbrava, Apostolia M. Tsimberidou, David S. Hong, Jordi Rodon Ahnert, Denái R. Milton, Xiaofeng Zheng, Daniel J. Booser, Nuhad K. Ibrahim, Anthony P. Conley, Priya Bhosale, Cristhiam M. Rojas Hernandez
Research output: Contribution to journal › Article › peer-review